日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語(yǔ)Fran?ais
Opinion
Home / Opinion / Opinion Line

No tariffs on targeted cancer drugs will reduce the price pain for patients

China Daily | Updated: 2018-03-22 07:07
Share
Share - WeChat

Premier Li Keqiang promises zero tariff rates for targeted cancer drugs at a news conference after the two sessions in Beijing on Tuesday. Thepaper.cn comments:

It is estimated more than 2 million people die of cancer in China each year. If there are zero tariffs, the retail price of the imported lifesaving drugs used in targeted cancer therapies will drop markedly. Their high prices have resulted in a large number of cancer patients exhausting their savings to extend their lives for a short time.

Some imported targeted cancer therapies can cost a patient as much as 10,000 yuan ($1,579) a dose as they are not covered by the medical insurance system. The high prices mean many patients have to give up their treatment.

More and more patients have turned to buying medicines from India through various channels as the prices are much lower, or to generic drugs that are lower in both price and efficiency. They then take the medicines at home without professional instruction and monitoring, further risking their health.

Aside from the tariffs, the high retail price of imported drugs in China is also pushed up by agents' fees, value-added tax, and high basic prices, which stem from the super-national treatment that some foreign medicines have been enjoying in the drug procurement of public hospitals, even if some of their patent protections have expired.

The pledge to end the tariffs on targeted cancer therapies indicates that the government recognizes they are special goods concerning people's welfare. But even without the tariffs, there still remains considerable room to squeeze the profit links between customs and patients to further bring down the prices of the drugs.

That the government has to open doors to imported drugs to save people's lives should also ring alarm bells for domestic pharmaceutical companies, especially the State-owned ones, as they have no reasons to sit idle, and are obliged to strengthen their research into these badly needed medicines and try their best to acquire the ability of producing them as early as possible.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 亚洲欧美视频网站 | 懂色一区二区三区免费观看 | 中文字幕人成乱码在线观看 | 84pao强力打造 | 国内精品久久毛片一区二区 | 日韩欧美综合在线二区三区 | a视频在线观看免费 | 国产精品99一区二区三区 | 91高清网站| heyzo欧美 | 亚洲日本高清成人aⅴ片 | 谍影在线观看电视剧完整版 | 成人亚洲A片V一区二区三区婷婷 | 日韩成人中文字幕 | 天天视频国产 | 国产精品免费久久久免费 | 国产在线精品一区二区三区 | 天堂久久久久久中文字幕 | 精品在线一区二区三区 | 久久99热这里只频精品6中文字幕 | 国产亚洲蜜芽精品久久 | 日本黄a | 国产欧美一级二级三级在线视频 | 国产91影院 | 91精选视频 | 国产成人免费全部网站 | 激情五月综合 | 亚洲产国偷V产偷V自拍A片 | 亚洲午夜无码毛片AV久久 | 我把寡妇日出水好爽视频 | 色开心婷婷 | 亚洲高清视频一区二区 | 狠狠色噜噜狠狠狠狠米奇777 | 国产精品99爱免费视频 | 狠狠一区| 日韩欧美h | 久久久久久亚洲 | 国产精品成人不卡在线观看 | 91www在线观看 | 欧美日韩大片在线观看 | 超91在线|